Molecular pathogenesis of leukemia and leukemic stem cells (LSCs).

作者信息

Kizaki Masahiro

机构信息

Department of Hematology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama, 350-8550, Japan.

出版信息

Int J Hematol. 2019 Jan;109(1):3-4. doi: 10.1007/s12185-018-2550-z. Epub 2018 Oct 23.

DOI:10.1007/s12185-018-2550-z

PMID:30353275

Abstract

摘要

相似文献

Molecular pathogenesis of leukemia and leukemic stem cells (LSCs).

Int J Hematol. 2019 Jan;109(1):3-4. doi: 10.1007/s12185-018-2550-z. Epub 2018 Oct 23.

Leukemic stem cells: a review.

Cancer Invest. 2013 May;31(4):215-20. doi: 10.3109/07357907.2012.700986. Epub 2013 Mar 8.

[Molecular targeted therapy for leukemic stem cells].

Nihon Rinsho. 2015 May;73(5):811-5.

Leukemia Stem Cells Microenvironment.

Adv Exp Med Biol. 2017;1041:19-32. doi: 10.1007/978-3-319-69194-7_3.

Considerations for targeting malignant stem cells in leukemia.

Cancer Control. 2004 Mar-Apr;11(2):97-104. doi: 10.1177/107327480401100216.

Targeting the leukemic stem cell: the Holy Grail of leukemia therapy.

Leukemia. 2009 Jan;23(1):25-42. doi: 10.1038/leu.2008.246. Epub 2008 Sep 18.

Leukemia stem cells in drug resistance and metastasis.

Chin Med J (Engl). 2010 Apr 5;123(7):954-60.

Understanding of leukemic stem cells and their clinical implications.

Mol Cancer. 2017 Jan 30;16(1):2. doi: 10.1186/s12943-016-0574-7.

[Progress in the leukemic stem cell study and a novel therapeutic approach targeting leukemic stem cells].

Rinsho Ketsueki. 2017;58(10):1838-1843. doi: 10.11406/rinketsu.58.1838.

Bmi1 is essential for leukemic reprogramming of myeloid progenitor cells.

Leukemia. 2011 Aug;25(8):1335-43. doi: 10.1038/leu.2011.85. Epub 2011 Apr 29.

本文引用的文献

Hematopoietic stem cell fate through metabolic control.

Exp Hematol. 2018 Aug;64:1-11. doi: 10.1016/j.exphem.2018.05.005. Epub 2018 May 25.

Identification of novel lncRNAs regulated by the TAL1 complex in T-cell acute lymphoblastic leukemia.

Leukemia. 2018 Oct;32(10):2138-2151. doi: 10.1038/s41375-018-0110-4. Epub 2018 Mar 26.

TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia.

Exp Hematol. 2017 Sep;53:7-15. doi: 10.1016/j.exphem.2017.06.001. Epub 2017 Jun 24.

European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia.

Leukemia. 2016 Aug;30(8):1648-71. doi: 10.1038/leu.2016.104. Epub 2016 Apr 28.

A Cell-Based High-Throughput Screening for Inducers of Myeloid Differentiation.

J Biomol Screen. 2015 Oct;20(9):1150-9. doi: 10.1177/1087057115592220. Epub 2015 Jun 24.

Metabolic requirements for the maintenance of self-renewing stem cells.

Nat Rev Mol Cell Biol. 2014 Apr;15(4):243-56. doi: 10.1038/nrm3772.

Leukemic stem cells: a review.

Cancer Invest. 2013 May;31(4):215-20. doi: 10.3109/07357907.2012.700986. Epub 2013 Mar 8.

Autonomous murine T-cell progenitor production in the extra-embryonic yolk sac before HSC emergence.

Blood. 2012 Jun 14;119(24):5706-14. doi: 10.1182/blood-2011-12-397489. Epub 2012 Mar 19.

Embryonic day 9 yolk sac and intra-embryonic hemogenic endothelium independently generate a B-1 and marginal zone progenitor lacking B-2 potential.

Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1468-73. doi: 10.1073/pnas.1015841108. Epub 2011 Jan 5.

Transcription factors in myeloid development: balancing differentiation with transformation.

Nat Rev Immunol. 2007 Feb;7(2):105-17. doi: 10.1038/nri2024.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Molecular pathogenesis of leukemia and leukemic stem cells (LSCs).

Int J Hematol. 2019 Jan;109(1):3-4. doi: 10.1007/s12185-018-2550-z. Epub 2018 Oct 23.

Leukemic stem cells: a review.

Cancer Invest. 2013 May;31(4):215-20. doi: 10.3109/07357907.2012.700986. Epub 2013 Mar 8.

[Molecular targeted therapy for leukemic stem cells].

Nihon Rinsho. 2015 May;73(5):811-5.

Leukemia Stem Cells Microenvironment.

Adv Exp Med Biol. 2017;1041:19-32. doi: 10.1007/978-3-319-69194-7_3.

Considerations for targeting malignant stem cells in leukemia.

Cancer Control. 2004 Mar-Apr;11(2):97-104. doi: 10.1177/107327480401100216.

Targeting the leukemic stem cell: the Holy Grail of leukemia therapy.

Leukemia. 2009 Jan;23(1):25-42. doi: 10.1038/leu.2008.246. Epub 2008 Sep 18.

Leukemia stem cells in drug resistance and metastasis.

Chin Med J (Engl). 2010 Apr 5;123(7):954-60.

Understanding of leukemic stem cells and their clinical implications.

Mol Cancer. 2017 Jan 30;16(1):2. doi: 10.1186/s12943-016-0574-7.

[Progress in the leukemic stem cell study and a novel therapeutic approach targeting leukemic stem cells].

Rinsho Ketsueki. 2017;58(10):1838-1843. doi: 10.11406/rinketsu.58.1838.

Bmi1 is essential for leukemic reprogramming of myeloid progenitor cells.

Leukemia. 2011 Aug;25(8):1335-43. doi: 10.1038/leu.2011.85. Epub 2011 Apr 29.

本文引用的文献

Hematopoietic stem cell fate through metabolic control.

Exp Hematol. 2018 Aug;64:1-11. doi: 10.1016/j.exphem.2018.05.005. Epub 2018 May 25.

Identification of novel lncRNAs regulated by the TAL1 complex in T-cell acute lymphoblastic leukemia.

Leukemia. 2018 Oct;32(10):2138-2151. doi: 10.1038/s41375-018-0110-4. Epub 2018 Mar 26.

TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia.

Exp Hematol. 2017 Sep;53:7-15. doi: 10.1016/j.exphem.2017.06.001. Epub 2017 Jun 24.

European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia.

Leukemia. 2016 Aug;30(8):1648-71. doi: 10.1038/leu.2016.104. Epub 2016 Apr 28.

A Cell-Based High-Throughput Screening for Inducers of Myeloid Differentiation.

J Biomol Screen. 2015 Oct;20(9):1150-9. doi: 10.1177/1087057115592220. Epub 2015 Jun 24.

Metabolic requirements for the maintenance of self-renewing stem cells.

Nat Rev Mol Cell Biol. 2014 Apr;15(4):243-56. doi: 10.1038/nrm3772.

Leukemic stem cells: a review.

Cancer Invest. 2013 May;31(4):215-20. doi: 10.3109/07357907.2012.700986. Epub 2013 Mar 8.

Autonomous murine T-cell progenitor production in the extra-embryonic yolk sac before HSC emergence.

Blood. 2012 Jun 14;119(24):5706-14. doi: 10.1182/blood-2011-12-397489. Epub 2012 Mar 19.

Embryonic day 9 yolk sac and intra-embryonic hemogenic endothelium independently generate a B-1 and marginal zone progenitor lacking B-2 potential.

Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1468-73. doi: 10.1073/pnas.1015841108. Epub 2011 Jan 5.

Transcription factors in myeloid development: balancing differentiation with transformation.

Nat Rev Immunol. 2007 Feb;7(2):105-17. doi: 10.1038/nri2024.